Best Countries for Biotech / Life Sciences
Drug development, medical devices, diagnostics, and life science tools. Regulatory pathway clarity and R&D credits drive location decisions.
Industry Weights vs Default
The bars below show how each dimension is weighted for Biotech / Life Sciences versus the default equal-ish weighting. Dimensions with higher weight have more impact on the final score.
Singapore ranks #1 for Biotech / Life Sciences primarily due to its strong corporate tax position (100/100), making it a compelling base for profitable Biotech / Life Sciences operations.
- Corporate tax: scores 100/100 on NomadSignal's corporate tax dimension
- Patent Regime for Biologics: 80/100 on this Biotech / Life Sciences-specific dimension
- Startup ecosystem: 100/100 with established VC community and accelerators
United Kingdom ranks #2 on the strength of its startup ecosystem (100/100), providing the talent, capital, and institutional support that Biotech / Life Sciences companies require to scale.
- Startup ecosystem: scores 100/100 on NomadSignal's startup ecosystem dimension
- Patent Regime for Biologics: 85/100 on this Biotech / Life Sciences-specific dimension
- Startup ecosystem: 100/100 with established VC community and accelerators
Canada ranks #3 for Biotech / Life Sciences with an industry-weighted score of 68/100, balancing strong scores across operational ease and residency pathways.
- Operational ease: scores 96/100 on NomadSignal's operational ease dimension
- Clinical Trial Environment: 88/100 on this Biotech / Life Sciences-specific dimension
- Startup ecosystem: 90/100 with established VC community and accelerators
Estonia ranks #4 for Biotech / Life Sciences with an industry-weighted score of 68/100, balancing strong scores across family viability and operational ease.
- Family viability: scores 100/100 on NomadSignal's family viability dimension
- Patent Regime for Biologics: 65/100 on this Biotech / Life Sciences-specific dimension
- EU funding eligible: access to Horizon Europe, EIC Accelerator, and regional grant programs
Italy earns its #5 ranking through superior funding access (100/100), with an active VC ecosystem and government co-investment programs particularly suited to Biotech / Life Sciences startups.
- Funding access: scores 100/100 on NomadSignal's funding access dimension
- Clinical Trial Environment: 78/100 on this Biotech / Life Sciences-specific dimension
- EU funding eligible: access to Horizon Europe, EIC Accelerator, and regional grant programs
What is the best country for Biotech / Life Sciences startups in 2026?
Based on NomadSignal's Biotech / Life Sciences-weighted scoring model, Singapore ranks #1 with 73/100. It scores strongly on corporate tax and startup ecosystem, which carry the highest combined weight in the Biotech / Life Sciences model. United Kingdom is the closest challenger at 70/100. The right jurisdiction depends on your specific situation - tax residency, team location, and funding strategy all affect the optimal choice.
What corporate tax rate do Biotech / Life Sciences companies pay in Singapore?
Singapore scores 100/100 on NomadSignal's corporate tax dimension, which incorporates the statutory rate, territorial treatment, IP box availability, and treaty network breadth. For Biotech / Life Sciences companies, tax efficiency is weighted at 8% of the total score. Founders should verify the current effective rate with a local tax advisor, as special regimes and holding structures can significantly alter the actual rate paid.
Does Singapore have special programs for Biotech / Life Sciences companies?
Singapore scores 85/100 on NomadSignal's funding dimension, reflecting its combination of government grants, VC ecosystem depth, and co-investment programs. Beyond standard funding, NomadSignal also evaluates Biotech / Life Sciences-specific factors including Regulatory Approval Pathway, Clinical Trial Environment, Patent Regime for Biologics, all of which contribute to Singapore's position in the Biotech / Life Sciences rankings. For up-to-date program details, check the government innovation agency and startup association in Singapore directly.
Which region is best for Biotech / Life Sciences startups?
Europe leads with 8 jurisdictions in the top 10 for Biotech / Life Sciences. The region benefits from competitive cost structures and growing startup ecosystems. However, the best region for your specific company depends on where your customers, co-founders, and investors are located.
How does NomadSignal score Biotech / Life Sciences jurisdictions?
NomadSignal scores Biotech / Life Sciences jurisdictions across 9 base dimensions plus 3 Biotech / Life Sciences-specific dimensions. The base dimensions are re-weighted for this industry: the top contributors are funding (12%), ecosystem (10%), corporate tax (8%). Industry-specific dimensions include Regulatory Approval Pathway (15%), Clinical Trial Environment (10%), Patent Regime for Biologics (5%). All scores are computed from structured jurisdiction data updated as policy changes occur. No LLM generates the scores - they are derived from verifiable data fields.
Side-by-Side Comparison
Compare any two jurisdictions across all 9 dimensions.
Open toolExplore All Jurisdictions
Browse detailed profiles for 22+ countries.
Browse countriesData as of March 2026. Not legal, tax, or immigration advice.